1) Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004; 8: R204-12
|
|
|
2) Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007; 11: R31
|
|
|
3) Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005; 16: 3365-70
|
|
|
4) Lassnigg A, Schmid ER, Hiesmayr M, et al. Impact of minimal increases in serum creatinine on outcome in patients after cardiothoracic surgery: do we have to revise current definitions of acute renal failure? Crit Care Med. 2008; 36: 1129-37
|
|
|
5) Macedo E, Bouchard J, Soroko SH, et al. Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients. Crit Care. 2010; 14: R82
|
|
|
6) Barrantes F, Tian J, Vazquez R, et al. Acute kidney injury criteria predict outcomes of critically ill patients. Crit Care Med. 2008; 36: 1397-403
|
|
|
7) Macedo E, Malhotra R, Claure-Del Granado R, et al. Defining urine output criterion for acute kidney injury in critically ill patients. Nephrol Dial Transplant. 2010 Jun 17. [Epub ahead of print]
|
|
|
8) Oliver J, Mac DM, Tracy A. The pathogenesis of acute renal failure associated with traumatic and toxic injury; renal ischemia, nephrotoxic damage and the ischemic episode. J Clin Invest. 1951; 30: 1): 1307-439
|
|
|
9) Finckh ES, Jeremy D, Whyte HM. Structural renal damage and its relatin to clinical features in acute oliguric renal failure. Q J Med. 1962; 31: 429-46
|
|
|
10) Molitoris BA. New insights into the cell biology of ischemic acute renal failure. J Am Soc Nephrol. 1991; 1: 1263-70
|
|
|
11) Padanilam BJ. Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis. Am J Physiol Renal Physiol. 2003; 284: F608-27
|
|
|
12) Sugiura H, Yoshida T, Mitobe M, et al. Klotho reduces apoptosis in experimental ischaemic acute kidney injury via HSP-70. Nephrol Dial Transplant. 2010; 25: 60-8
|
|
|
13) Westhoff JH, Schildhorn C, Jacobi C, et al. Telomere shortening reduces regenerative capacity after acute kidney injury. J Am Soc Nephrol. 2010; 21: 327-36
|
|
|
14) Heemskerk S, Masereeuw R, Russel FG, et al. Selective iNOS inhibition for the treatment of sepsis-induced acute kidney injury. Nat Rev Nephrol. 2009; 5: 629-40
|
|
|
15) Langenberg C, Bagshaw SM, May CN, et al. The histopathology of septic acute kidney injury: a systematic review. Crit Care. 2008; 12: R38
|
|
|
16) Messaris E, Memos N, Chatzigianni E, et al. Apoptotic death of renal tubular cells in experimental sepsis. Surg Infect (Larchmt). 2008; 9: 377-88
|
|
|
17) Mariano F, Cantaluppi V, Stella M, et al. Circulating plasma factors induce tubular and glomerular alterations in septic burns patients. Crit Care. 2008; 12: R42
|
|
|
18) Cantaluppi V, Weber V, Lauritano C, et al. Protective effect of resin adsorption on septic plasma-induced tubular injury. Crit Care. 2010; 14: R4
|
|
|
19) Ranieri VM, Suter PM, Tortorella C, et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1999; 282: 54-61
|
|
|
20) Kuiper JW, Versteilen AM, Niessen HW, et al. Production of endothelin-1 and reduced blood flow in the rat kidney during lung-injurious mechanical ventilation. Anesth Analg. Oct 2008; 107: 1276-83
|
|
|
21) Grigoryev DN, Liu M, Hassoun HT, et al. The local and systemic inflammatory transcriptome after acute kidney injury. J Am Soc Nephrol. 2008; 19: 547-58
|
|
|
22) Vaschetto R, Kuiper JW, Musters RJ, et al. Renal hypoperfusion and impaired endothelium-dependent vasodilation in an animal model of VILI: the role of the peroxynitrite-PARP pathway. Crit Care. 2010; 14: R45
|
|
|
23) Paladino JD, Hotchkiss JR, Rabb H. Acute kidney injury and lung dysfunction: a paradigm for remote organ effects of kidney disease? Microvasc Res. 2009; 77: 8-12
|
|
|
24) Liu M, Liang Y, Chigurupati S, et al. Acute kidney injury leads to inflammation and functional changes in the brain. J Am Soc Nephrol. 2008; 19: 1360-70
|
|
|
25) Gris D, Hamilton EF, Weaver LC. The systemic inflammatory response after spinal cord injury damages lungs and kidneys. Exp Neurol. 2008; 211: 259-70
|
|
|
26) Vaidya VS, Ferguson MA, Bonventre JV. Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol. 2008; 48: 463-93
|
|
|
27) Coca SG, Yalavarthy R, Concato J, et al. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int. 2008; 73: 1008-16
|
|
|
28) Herget-Rosenthal S, Marggraf G, Husing J, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int. 2004; 66: 1115-22
|
|
|
29) Nejat M, Pickering JW, Walker RJ, et al. Rapid detection of acute kidney injury by plasma cystatin C in the intensive care unit. Nephrol Dial Transplant. 2010; 25: 3283-9
|
|
|
30) Krawczeski CD, Vandevoorde RG, Kathman T, et al. Serum cystatin C is an early predictive biomarker of acute kidney injury after pediatric cardiopulmonary bypass. Clin J Am Soc Nephrol. 2010; 5: 1552-7
|
|
|
31) Soto K, Coelho S, Rodrigues B, et al. Cystatin C as a marker of acute kidney injury in the emergency department. Clin J Am Soc Nephrol. 2010; 5: 1745-54
|
|
|
32) Nejat M, Pickering JW, Walker RJ, et al. Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit. Crit Care. 2010; 14: R85
|
|
|
33) Bagshaw SM, Bennett M, Haase M, et al. Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med. 2010; 36: 452-61
|
|
|
34) Makris K, Markou N, Evodia E, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients. Clin Chem Lab Med. 2009; 47: 79-82
|
|
|
35) Cruz DN, de Cal M, Garzotto F, et al. Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med. 2010; 36: 444-51
|
|
|
36) Kumpers P, Hafer C, Lukasz A, et al. Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury. Crit Care. 2010; 14: R9
|
|
|
37) Haase-Fielitz A, Bellomo R, Devarajan P, et al. The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrol Dial Transplant. 2009; 24: 3349-54
|
|
|
38) McIlroy DR, Wagener G, Lee HT. Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance. Clin J Am Soc Nephrol. 2010; 5: 211-9
|
|
|
39) Yang J, Goetz D, Li JY, et al. An iron delivery pathway mediated by a lipocalin. Mol Cell. 2002; 10: 1045-56
|
|
|
40) Mori K, Lee HT, Rapoport D, et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest. 2005; 115: 610-21
|
|
|
41) Waanders F, van Timmeren MM, Stegeman CA, et al. Kidney injury molecule-1 in renal disease. J Pathol. 2010; 220: 7-16
|
|
|
42) Chiusolo A, Defazio R, Zanetti E, et al. Kidney injury molecule-1 expression in rat proximal tubule after treatment with segment-specific nephrotoxicants: a tool for early screening of potential kidney toxicity. Toxicol Pathol. 2010; 38: 338-45
|
|
|
43) Vaidya VS, Ozer JS, Dieterle F, et al. Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol. 2010; 28: 478-85
|
|
|
44) Nogare AL, Joelsons G, Pedroso JA, et al. Quantitative analyses of kidney injury molecule-1 messenger RNA in kidney transplant recipients with graft dysfunction. Transplant Proc. 2010; 42: 473-4
|
|
|
45) Correa-Rotter R, Hostetter TH, Manivel JC, et al. Intrarenal distribution of clusterin following reduction of renal mass. Kidney Int. 1992; 41: 938-50
|
|
|
46) Ishii A, Sakai Y, Nakamura A. Molecular pathological evaluation of clusterin in a rat model of unilateral ureteral obstruction as a possible biomarker of nephrotoxicity. Toxicol Pathol. 2007; 35: 376-82
|
|
|
47) Zhou W, Guan Q, Kwan CC, et al. Loss of clusterin expression worsens renal ischemia-reperfusion injury. Am J Physiol Renal Physiol. 2010; 298: F568-78
|
|
|
48) Dieterle F, Perentes E, Cordier A, et al. Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury. Nat Biotechnol. 2010; 28: 463-9
|
|
|